Amil, Dasa rivals split on potential impact of joint venture in Brazil
The Brazilian national authority has received 72 responses from hospitals, medical clinics and health insurers as part of its investigation into the joint venture between Amil and Dasa. Four respondents agreed...To view the full article, register now.
Already a subscriber? Click here to view full article